NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
3.69
Dollar change
-0.12
Percentage change
-3.15
%
Index- P/E- EPS (ttm)-0.20 Insider Own5.71% Shs Outstand27.18M Perf Week-1.86%
Market Cap101.37M Forward P/E- EPS next Y-0.12 Insider Trans0.00% Shs Float25.90M Perf Month-6.82%
Enterprise Value81.65M PEG- EPS next Q-0.06 Inst Own30.31% Short Float1.14% Perf Quarter76.56%
Income-5.23M P/S5.19 EPS this Y15.00% Inst Trans47.22% Short Ratio0.37 Perf Half Y103.87%
Sales19.53M P/B3.26 EPS next Y32.35% ROA-13.09% Short Interest0.30M Perf YTD101.64%
Book/sh1.13 P/C5.06 EPS next 5Y- ROE-16.53% 52W Range1.18 - 4.01 Perf Year147.65%
Cash/sh0.73 P/FCF- EPS past 3/5Y22.27% 21.98% ROIC-16.94% 52W High-8.09% Perf 3Y-3.15%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-16.47% -8.95% Gross Margin84.36% 52W Low212.71% Perf 5Y-68.41%
Dividend TTM- EV/Sales4.18 EPS Y/Y TTM-68.28% Oper. Margin-30.50% Volatility3.15% 2.42% Perf 10Y-4.90%
Dividend Ex-Date- Quick Ratio3.57 Sales Y/Y TTM-0.53% Profit Margin-26.77% RSI (14)48.84 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio3.66 EPS Q/Q32.76% SMA20-2.87% Beta1.40 Target Price5.50
Payout- Debt/Eq0.01 Sales Q/Q-1.61% SMA506.46% Rel Volume0.34 Prev Close3.81
Employees66 LT Debt/Eq0.00 EarningsMay 13 AMC SMA20053.45% Avg Volume809.51K Price3.69
IPODec 13, 1984 Option/ShortYes / Yes EPS/Sales Surpr.68.00% 7.39% Trades Volume278,916 Change-3.15%
Date Action Analyst Rating Change Price Target Change
Apr-17-25Downgrade Laidlaw Buy → Hold
Apr-17-25Downgrade BTIG Research Buy → Neutral
Jan-18-22Downgrade Guggenheim Buy → Neutral
Apr-22-21Initiated Guggenheim Buy $24
Mar-23-21Initiated BTIG Research Buy $25
Feb-26-21Initiated Oppenheimer Outperform $27
Jan-29-21Initiated Cantor Fitzgerald Overweight $19
Dec-03-20Initiated B. Riley Securities Buy $15
Feb-05-20Initiated JMP Securities Mkt Outperform $15
Jan-09-20Initiated Lake Street Buy $14
May-13-25 04:17PM
04:01PM
11:28AM
Apr-30-25 10:53AM
Apr-29-25 11:12AM
08:00AM Loading…
08:00AM
Apr-15-25 04:01PM
Apr-08-25 10:19AM
Mar-20-25 03:02AM
Mar-19-25 07:01PM
07:00PM
04:17PM
04:01PM
Mar-11-25 08:00AM
Mar-05-25 02:04PM
05:55PM Loading…
Feb-27-25 05:55PM
Feb-26-25 02:46PM
Feb-21-25 07:59AM
Feb-20-25 11:44AM
Feb-19-25 08:00AM
Feb-03-25 07:12PM
Jan-27-25 09:31AM
08:00AM
Dec-11-24 10:00AM
Dec-04-24 05:00PM
Nov-26-24 01:00PM
Nov-14-24 11:22AM
Nov-13-24 04:12PM
04:01PM
Nov-12-24 08:00AM
08:00AM Loading…
Nov-06-24 08:00AM
Nov-05-24 08:00AM
Oct-24-24 02:00PM
Oct-16-24 08:00AM
Oct-09-24 06:19PM
Oct-03-24 08:00AM
Sep-20-24 08:00AM
Sep-11-24 08:00AM
Aug-13-24 04:14PM
04:01PM
Aug-06-24 08:00AM
Jul-29-24 08:00AM
Jun-26-24 08:00AM
Jun-04-24 08:00AM
May-17-24 07:00AM
May-16-24 03:01AM
May-15-24 11:52AM
08:00AM
07:57AM
May-08-24 09:49AM
May-02-24 08:00AM
Apr-11-24 08:00AM
Apr-09-24 08:00AM
Apr-08-24 04:29PM
Apr-03-24 08:00AM
Apr-02-24 08:00AM
Mar-19-24 09:00AM
Mar-14-24 02:00PM
Mar-13-24 08:46AM
07:01AM
Mar-12-24 04:22PM
04:01PM
Mar-01-24 07:30AM
Feb-28-24 08:05AM
Feb-27-24 09:05AM
08:05AM
Feb-06-24 08:00AM
Jan-30-24 08:00AM
Dec-18-23 08:00AM
Dec-05-23 06:00AM
Nov-28-23 08:00AM
Nov-27-23 08:00AM
Nov-22-23 08:12AM
Nov-20-23 08:00AM
Nov-14-23 10:56AM
08:00AM
Nov-13-23 04:06PM
04:01PM
Oct-30-23 08:00AM
Oct-24-23 04:03PM
Oct-23-23 08:01AM
Oct-08-23 07:19PM
Sep-01-23 05:07AM
Aug-27-23 11:53AM
Aug-16-23 08:00AM
Aug-15-23 07:58AM
Aug-14-23 05:48PM
04:01PM
08:00AM
Aug-07-23 11:49AM
Jul-31-23 08:00AM
Jul-25-23 09:34PM
Jul-23-23 09:49AM
Jul-18-23 08:00AM
Jul-12-23 08:00AM
Jul-10-23 08:00AM
Jul-07-23 02:30PM
Jun-25-23 02:17PM
Jun-08-23 06:31AM
May-18-23 04:40PM
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.